Gilead Sciences GILD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.02B+53.7% | $2.18B+22.4% | $3.05B+144% | $1.96B+21.4% | $1.32B+132% | ||
| $218M+4.3% | $230M+3.6% | $230M+6.5% | $225M+7.1% | $209M+11.8% | ||
| $2.54B+44.8% | $3.33B+11.8% | $4.11B-4.7% | $827M-37.6% | $1.76B-20.8% | ||
| $117M+12.5% | $205M+39.5% | $147M+4.3% | $107M-17.7% | $104M-1.0% | ||
| $109M-60.1% | $609M+712% | $167M-70.7% | $21M-86.2% | $273M-93.2% | ||
| $1.77B+527% | -$1.84B-716% | -$427M+39.9% | -$2.12B-589% | -$415M+81.2% | ||
| $1.04B+3.0% | $994M+2.2% | $1.01B+2.2% | $994M+2.3% | $1.01B+2.0% | ||
| $419M-42.6% | $230M-34.3% | $435M+45.0% | $527M+427% | $730M+82.5% | ||
| -$4.24B-23.7% | -$1.26B— | -$1.49B-8.0% | -$1.57B+46.9% | -$3.43B-152% | ||
| $65M+103% | —— | —— | -$2.78B-43.0% | -$2.07B-51.1% | ||
| $2.43B+46.8% | $3.12B+10.4% | $3.96B-5.0% | $720M-39.7% | $1.65B-21.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gilead Sciences generate?
- Gilead Sciences (GILD) generated $10.8B in operating cash flow over the trailing twelve months.
- What is Gilead Sciences's free cash flow?
- After $576.0M of capital expenditures, Gilead Sciences's free cash flow was $10.2B over the trailing twelve months, up 3.9% year over year.
- Where does Gilead Sciences's cash flow data come from?
- Every line is extracted from Gilead Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
